Brief: Microbix Biosystems Says Q4 Revenue Rose 108% To C$5.63 Mln
23/12/2021 13:00
Dec 23 (Reuters) - Microbix Biosystems Inc MBX.TO :
* Q4 REVENUE ROSE 108 PERCENT TO C$5.63 MILLION
* QTRLY NET COMPREHENSIVE INCOME PER SHARE $0.006
* MANAGEMENT CURRENTLY EXPECTS MICROBIX TO GENERATE
MEANINGFUL NET
EARNINGS GROWTH ACROSS FISCAL 2022
Source text for Eikon: ID:nGNX2SGCHN
Further company coverage: MBX.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Microbix Biosystems
See all newsCanada's Microbix Q3 revenue rises on higher antigen, QAPs sales
Brief: Microbix Biosystems Q3 Revenue CAD 4.1 Million
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Canada's Microbix Q1 revenue down 30% on China sales decline
Brief: Microbix Biosystems Q1 Revenue CAD 4.2 Million